international
New diabetes jab cuts weight by 15%, improves sugar control in global trial
Why this matters: an international story with cross-border implications worth tracking.
A new experimental diabetes jab, retatrutide, has shown promising Phase-3 trial results, helping type 2 diabetes patients lose up to 15% of body weight and significantly improve blood sugar control. The once-weekly injectable targets three hormone receptors, with the highest dose reducing HbA1c by 1
Read full story on Times of India → More top stories
Aggregated and edited by the Scoop newsroom. We surface news from Times of India alongside other reporting so you can compare coverage in one place.
Editorial policy · Corrections · About Scoop